Gabriela Hobbs/Massachusetts General Hospital
Sep 13, 2026, 04:22
Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School shared a post on LinkedIn:
“Great Society of Hematologic Oncology 2026 meeting!
Excited to present on updates in ET and PV, including two newly approved drugs!
Had a great time leading the MPN poster walk and so proud of my mentee and fellow, Kate Feder for her poster describing the MGB experience with ropeg.”
Stay updated with Hemostasis Today.
-
Oct 27, 2026, 23:04Stefano Navarro: Hypertension Reprogrammes Megakaryocytes and Increases Platelet Responsiveness to Thrombin
-
Oct 27, 2026, 23:03Enrique M. San Norberto García: What Is the Best Treatment for Femoropopliteal in-Stent Restenosis
-
Oct 27, 2026, 23:01Mandy-Lyn Crispim: One Donation Can Help Save More Than One Life
-
Oct 27, 2026, 23:00Teresa Buzzoni: AABB 2026 Through the Eyes of a Newcomer to the Blood Industry
-
Oct 27, 2026, 22:59Josephine Cantu: The Incredible Science Behind Blood Clotting – A Life-Saving Process
-
Oct 27, 2026, 22:56Edward Lee Carter: First Factor XIa Inhibitor Approved Worldwide – U.S. FDA Decision Expected in November
-
Oct 27, 2026, 22:56Anne Troldborg: Preventing Thrombosis in SLE Before the First Event
-
Oct 27, 2026, 22:53Shadi Tabibian: Tazehnameh November 2026 Covers Key Developments in Hemophilia Care
-
Oct 27, 2026, 22:52Danny Hsu: THANZ Makes History With Its First Dedicated HHT Symposium at Blood 2026